189 related articles for article (PubMed ID: 8819585)
1. HIV protease inhibitors.
Winslow DL; Otto MJ
AIDS; 1995; 9 Suppl A():S183-92. PubMed ID: 8819585
[No Abstract] [Full Text] [Related]
2. Update of the drug resistance mutations in HIV-1: 2004.
Johnson VA; Brun-Vézinet F; Clotet B; Conway B; D'Aquila RT; Demeter LM; Kuritzkes DR; Pillay D; Schapiro JM; Telenti A; Richman DD
Top HIV Med; 2004; 12(4):119-24. PubMed ID: 15516709
[No Abstract] [Full Text] [Related]
3. [HIV: less resistance due to combined treatment].
Dtsch Med Wochenschr; 1996 Dec; 121(49):A47-8. PubMed ID: 8998914
[No Abstract] [Full Text] [Related]
4. [Primary resistance to antiretroviral agents].
Soriano V; María Miró J; Guerrero A
Enferm Infecc Microbiol Clin; 2001 Feb; 19(Monografico):22-5. PubMed ID: 11428054
[No Abstract] [Full Text] [Related]
5. HIV-protease inhibitors.
Flexner C
N Engl J Med; 1998 Apr; 338(18):1281-92. PubMed ID: 9562584
[No Abstract] [Full Text] [Related]
6. [Human immunodeficiency virus and antiretroviral therapy resistance].
Quirós E; Torti C; Carosi G
Enferm Infecc Microbiol Clin; 2000 May; 18(5):234-7. PubMed ID: 10974768
[No Abstract] [Full Text] [Related]
7. [Biological basis for generating resistance to antiretroviral drugs].
Alcamí J; Delgado R; Menéndez-Arias L
Enferm Infecc Microbiol Clin; 2001 Feb; 19(Monografico):3-13. PubMed ID: 11428056
[No Abstract] [Full Text] [Related]
8. [New trends in HIV].
Volkert R
Dtsch Med Wochenschr; 1998 Sep; 123(38):A7. PubMed ID: 9787287
[No Abstract] [Full Text] [Related]
9. On the issue of cross-resistance between protease inhibitors.
Birch C
AIDS; 1998 Apr; 12(6):680-1. PubMed ID: 9583615
[No Abstract] [Full Text] [Related]
10. Novel arylsulfonamides possessing sub-picomolar HIV protease activities and potent anti-HIV activity against wild-type and drug-resistant viral strains.
Miller JF; Furfine ES; Hanlon MH; Hazen RJ; Ray JA; Robinson L; Samano V; Spaltenstein A
Bioorg Med Chem Lett; 2004 Feb; 14(4):959-63. PubMed ID: 15013001
[TBL] [Abstract][Full Text] [Related]
11. Salvage therapy for patients failing their current antiretroviral regimen.
Albrecht MA
AIDS Clin Rev; 2000-2001; ():139-91. PubMed ID: 10999220
[No Abstract] [Full Text] [Related]
12. Highly active antiretroviral therapy failure and protease and reverse transcriptase human immunodeficiency virus type 1 gene mutations.
Monno L; Appice A; Cavaliere R; Scarabaggio T; Angarano G
J Infect Dis; 1999 Aug; 180(2):568-71. PubMed ID: 10395885
[No Abstract] [Full Text] [Related]
13. Among the devils in the details are protease sequence, susceptibility, and structure in CRF02_AG viruses.
Katzenstein D; Ogden R
Clin Infect Dis; 2005 Jul; 41(2):252-4. PubMed ID: 15983924
[No Abstract] [Full Text] [Related]
14. Protease inhibitors: resistance, cross-resistance, fitness and the choice of initial and salvage therapies.
Erickson JW; Gulnik SV; Markowitz M
AIDS; 1999; 13 Suppl A():S189-204. PubMed ID: 10885776
[No Abstract] [Full Text] [Related]
15. [Resistance to protease inhibitors].
Clotet B; Martínez-Picado J; Arrizabalaga J; Ruiz L
Enferm Infecc Microbiol Clin; 2001 Feb; 19(Monografico):34-41. PubMed ID: 11428058
[No Abstract] [Full Text] [Related]
16. Beta-lactam compounds as apparently uncompetitive inhibitors of HIV-1 protease.
Sperka T; Pitlik J; Bagossi P; Tözsér J
Bioorg Med Chem Lett; 2005 Jun; 15(12):3086-90. PubMed ID: 15893929
[TBL] [Abstract][Full Text] [Related]
17. [Development of HIV protease inhibitors as anti AIDS drugs: molecular design based on substrate transition state].
Kiso Y
Tanpakushitsu Kakusan Koso; 1998 May; 43(6):725-33. PubMed ID: 9612066
[No Abstract] [Full Text] [Related]
18. Lysine sulfonamides as novel HIV-protease inhibitors: Nepsilon-acyl aromatic alpha-amino acids.
Stranix BR; Lavallée JF; Sévigny G; Yelle J; Perron V; LeBerre N; Herbart D; Wu JJ
Bioorg Med Chem Lett; 2006 Jul; 16(13):3459-62. PubMed ID: 16644213
[TBL] [Abstract][Full Text] [Related]
19. [HIV-1 protease inhibitors: cell metabolism and drug resistance (review)].
Bobkova MR
Ter Arkh; 2008; 80(10):77-80. PubMed ID: 19105421
[No Abstract] [Full Text] [Related]
20. Design and synthesis of sulfoximine based inhibitors for HIV-1 protease.
Raza A; Sham YY; Vince R
Bioorg Med Chem Lett; 2008 Oct; 18(20):5406-10. PubMed ID: 18829317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
